Search - tctmd.com

Displaying 1 - 20 of 42

Sort: Relevancy | Date

Presentation TCT 2025

TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates

Presenter: Hannah Kempton

October 27, 2025

Presentation TCT 2025

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

Presenter: Noah Tregobov

October 27, 2025

Presentation TCT 2025

TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method

Presenter: Dejing Feng

October 25, 2025

Presentation TCT 2025

TCT 1: One-Year Outcomes of the RESILIA Balloon-Expandable Transcatheter Valve: Survival, Hemodynamics, and Hypoattenuated Leaflet Thickening

Presenter: Kazuki Suruga

October 25, 2025

Presentation TCT 2023

TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis

Presenter: Thangam Natarajan

October 24, 2023

Presentation TCT 2023

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

Presenter: Shubhadarshini Pawar

October 24, 2023

Presentation TCT 2023

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

Presenter: Yousef Darestani

October 24, 2023

Presentation TCT 2023

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Presenter: Daniel Overduin

October 24, 2023

Presentation TVT 2023

Hypoatenuatted leaflet thickening or infective endocarditis- 1 year after TAVI complication

Presenter: Joanna Nawara-Skipirzepa

June 09, 2023

Presentation TCT 2022

TCT 363: Incidence and timing of device related thrombus in percutaneous implantable cardiac devices: A systematic review and meta-analysis

Presenter: Richard Jung

September 19, 2022

Presentation TCT 2022

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Presenter: Khawaja Akhtar

September 19, 2022

Presentation TCT 2022

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

Presenter: Mina Shafiei

September 19, 2022

Presentation TCT 2022

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

Presenter: Ali Azadani

September 19, 2022

Presentation TCT 2022

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Presenter: Norman Mangner

September 19, 2022

Presentation TCT 2022

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

Presenter: Yu Sato

September 17, 2022

Presentation TCT 2021

HALT: Long-Term Clinical Impact of Hypoattenuating Leaflet Thickening After TAVR

Presenter: Santiago Garcia

November 04, 2021

Presentation TVT 2021

Synthesizing the Valve Leaflet Thickening CT Sub-studies: Implications for Anti-Thrombotic Therapy and Indications for Post-TAVR CT-Imaging

Presenter: Raj Makkar

July 20, 2021

Presentation TCT 2020

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

Presenter: Jaffar Khan

October 14, 2020

Presentation TCT 2019

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

Presenter: Lars Sondergaard

September 26, 2019

Presentation TCT 2019

TCT 36: Clinical Predictors of Hypo-Attenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement with 320-Multislice Scanner: A Single Center Experience.

Presenter: Hashrul Rashid

September 25, 2019

Advertisement

TCT 39: Hypo-Attenuated Leaflet Thickening After Transcatheter Tricuspid Valve Replacement: A Proposed Severity Scale and Clinical Correlates

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

TCT 228: Automatic detection and grading analysis of hypoattenuated leaflet thickening (HALT) after TAVR using artificial intelligence based imaging evaluation method

TCT 1: One-Year Outcomes of the RESILIA Balloon-Expandable Transcatheter Valve: Survival, Hemodynamics, and Hypoattenuated Leaflet Thickening

TCT 732: Bridging Morphology and Flow: Exploring Their interplay in HALT Progression fFllowing TAVR Through CFD Analysis

TCT 588: Association of Prosthesis Deformation of Balloon-Expandable Transcatheter Aortic Valves With Subclinical Leaflet Thrombosis

TCT 492: A Data-Driven Bayesian Model To Predict Leaflet Thrombosis After Bioprosthetic Aortic Valve Replacement

TCT 258: Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Patients After Transcatheter Aortic Valve Implantation

Hypoatenuatted leaflet thickening or infective endocarditis- 1 year after TAVI complication

TCT 363: Incidence and timing of device related thrombus in percutaneous implantable cardiac devices: A systematic review and meta-analysis

TCT 362: Direct-acting Oral Anticoagulants versus Vitamin K Antagonists in Patients Undergoing Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

TCT 361: On the Likelihood of Leaflet Thrombosis following Transcatheter Pulmonary Valve Replacement

TCT 360: The Importance of Leaflet Design in Initiation and Growth of Leaflet Thrombosis in Transcatheter Aortic Valves

TCT 359: Continued Oral Anticoagulation With Non-Vitamin K Antagonist Oral Anticoagulants Versus Vitamin K Antagonists in Transcatheter Aortic Valve Implantation

Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

HALT: Long-Term Clinical Impact of Hypoattenuating Leaflet Thickening After TAVR

Synthesizing the Valve Leaflet Thickening CT Sub-studies: Implications for Anti-Thrombotic Therapy and Indications for Post-TAVR CT-Imaging

TCT 465: Implantation Characteristics and Development of Hypoattenuated Leaflet Thickening in Low Risk Patients undergoing Transcatheter Aortic Valve Replacement

Valve Leaflet Thickening and Thrombosis: Definitions, Frequency, Management, and Clinical Importance

TCT 36: Clinical Predictors of Hypo-Attenuated Leaflet Thickening Following Transcatheter Aortic Valve Replacement with 320-Multislice Scanner: A Single Center Experience.

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content